Biological properties of du-145 supernatant
CA 2315249 C · Owner: Ichim, Thomas · Inventors: Ichim, Thomas; Zhong, Zhaohui
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention discloses biologically useful properties of supernatant derived from the, prostate adenocarcinoma cell line DU-145. Supernatant from this cell line possesses the, ability to stimulate proliferation of T cells B cells, endothelial cells and , bone marrow cells in a dose-dependent manner. The properties of DU-145 supernatant can be used in, therapeutically to stimulate proliferation of certain cell types in a mammal.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 28, 2000 and granted June 18, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 28, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 28, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.